Aurora Cannabis Inc. Logo

Aurora Cannabis Inc.

ACB

(1.2)
Stock Price

4,20 USD

-87.83% ROA

-118.26% ROE

-0.53x PER

Market Cap.

402.887.046,70 USD

18.72% DER

0% Yield

-270.02% NPM

Aurora Cannabis Inc. Stock Analysis

Aurora Cannabis Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Aurora Cannabis Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.21x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a low debt to equity ratio (41%), which means it has a small amount of debt compared to the ownership it holds

3 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

4 ROE

The stock's ROE indicates a negative return (-130.04%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-72.59%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Aurora Cannabis Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Aurora Cannabis Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Aurora Cannabis Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Aurora Cannabis Inc. Revenue
Year Revenue Growth
2006 0
2007 0 0%
2008 40.834 100%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 1.439.271 100%
2016 18.067.000 92.03%
2017 55.196.000 67.27%
2018 247.939.000 77.74%
2019 278.906.000 11.1%
2020 245.252.000 -13.72%
2021 221.339.000 -10.8%
2022 200.860.000 -10.2%
2022 233.290.083 13.9%
2023 269.644.000 13.48%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Aurora Cannabis Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 307.926 100%
2014 432.384 28.78%
2015 565.140 23.49%
2016 314.000 -79.98%
2017 1.679.000 81.3%
2018 14.778.000 88.64%
2019 26.070.000 43.31%
2020 11.447.000 -127.75%
2021 10.389.000 -10.18%
2022 9.824.000 -5.75%
2022 6.561.316 -49.73%
2023 2.972.000 -120.77%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Aurora Cannabis Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 0
2007 0 0%
2008 185.349 100%
2009 49.986 -270.8%
2010 181.955 72.53%
2011 250.022 27.22%
2012 152.642 -63.8%
2013 280.666 45.61%
2014 2.608.189 89.24%
2015 3.928.197 33.6%
2016 14.397.000 72.72%
2017 80.415.000 82.1%
2018 279.404.000 71.22%
2019 265.175.000 -5.37%
2020 139.680.000 -89.84%
2021 126.969.000 -10.01%
2022 135.940.000 6.6%
2022 68.218.650 -99.27%
2023 114.748.000 40.55%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Aurora Cannabis Inc. EBITDA
Year EBITDA Growth
2006 -1.246
2007 -228.557 99.45%
2008 -144.515 -58.15%
2009 -57.184 -152.72%
2010 -185.362 69.15%
2011 -330.363 43.89%
2012 -402.446 17.91%
2013 -298.327 -34.9%
2014 -9.241.522 96.77%
2015 -4.749.090 -94.6%
2016 -12.983.000 63.42%
2017 -78.456.000 83.45%
2018 -214.662.000 63.45%
2019 -393.231.000 45.41%
2020 -137.200.000 -186.61%
2021 -143.089.000 4.12%
2022 -247.596.000 42.21%
2022 -210.744.810 -17.49%
2023 65.244.000 423.01%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Aurora Cannabis Inc. Gross Profit
Year Gross Profit Growth
2006 0
2007 0 0%
2008 40.834 100%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 -304.796 100%
2015 676.271 145.07%
2016 16.056.000 95.79%
2017 43.519.000 63.11%
2018 159.815.000 72.77%
2019 -33.539.000 576.5%
2020 -21.558.000 -55.58%
2021 21.225.000 201.57%
2022 17.560.000 -20.87%
2022 -64.359.839 127.28%
2023 204.668.000 131.45%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Aurora Cannabis Inc. Net Profit
Year Net Profit Growth
2006 1.267
2007 -177.286 100.71%
2008 -145.659 -21.71%
2009 -43.906 -231.75%
2010 -322.497 86.39%
2011 -315.760 -2.13%
2012 -393.489 19.75%
2013 -399.705 1.56%
2014 -9.518.369 95.8%
2015 -5.723.506 -66.3%
2016 -12.968.000 55.86%
2017 71.936.000 118.03%
2018 -290.837.000 124.73%
2019 -3.310.337.000 91.21%
2020 -693.625.000 -377.25%
2021 -1.717.624.000 59.62%
2022 -2.475.108.000 30.6%
2022 -265.328.670 -832.85%
2023 -69.624.000 -281.09%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Aurora Cannabis Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 -1 100%
2015 -1 0%
2016 -1 0%
2017 2 100%
2018 -436 100.23%
2019 -342 -27.19%
2020 -41 -734.15%
2021 -8 -485.71%
2022 -12 36.36%
2022 -8 -37.5%
2023 -1 -700%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Aurora Cannabis Inc. Free Cashflow
Year Free Cashflow Growth
2006 15.114
2007 -90.525 116.7%
2008 -39.037 -131.9%
2009 -64.772 39.73%
2010 -275.478 76.49%
2011 -278.889 1.22%
2012 -447.844 37.73%
2013 -3.045.620 85.3%
2014 -11.157.790 72.7%
2015 -8.656.312 -28.9%
2016 -36.224.000 76.1%
2017 -218.612.000 83.43%
2018 -606.543.000 63.96%
2019 -692.958.000 12.47%
2020 -263.659.000 -162.82%
2021 -142.051.000 -85.61%
2022 -127.953.000 -11.02%
2022 -35.704.000 -258.37%
2023 -26.812.000 -33.16%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Aurora Cannabis Inc. Operating Cashflow
Year Operating Cashflow Growth
2006 15.114
2007 -87.256 117.32%
2008 -39.037 -123.52%
2009 -3.084 -1165.79%
2010 -180.910 98.3%
2011 -277.979 34.92%
2012 -447.844 37.93%
2013 -139.794 -220.36%
2014 -3.324.178 95.79%
2015 -6.771.479 50.91%
2016 -10.506.000 35.55%
2017 -81.667.000 87.14%
2018 -192.245.000 57.52%
2019 -337.952.000 43.11%
2020 -210.577.000 -60.49%
2021 -109.838.000 -91.72%
2022 -115.821.000 5.17%
2022 -26.642.000 -334.73%
2023 -21.126.000 -26.11%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Aurora Cannabis Inc. Capital Expenditure
Year Capital Expenditure Growth
2006 0
2007 3.269 100%
2008 0 0%
2009 61.688 100%
2010 94.568 34.77%
2011 910 -10292.09%
2012 0 0%
2013 2.905.826 100%
2014 7.833.612 62.91%
2015 1.884.833 -315.61%
2016 25.718.000 92.67%
2017 136.945.000 81.22%
2018 414.298.000 66.95%
2019 355.006.000 -16.7%
2020 53.082.000 -568.79%
2021 32.213.000 -64.78%
2022 12.132.000 -165.52%
2022 9.062.000 -33.88%
2023 5.686.000 -59.37%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Aurora Cannabis Inc. Equity
Year Equity Growth
2006 430.222
2007 1.685.259 74.47%
2008 1.619.087 -4.09%
2009 1.714.212 5.55%
2010 1.372.626 -24.89%
2011 1.074.552 -27.74%
2012 694.200 -54.79%
2013 1.353.361 48.71%
2014 3.832.810 64.69%
2015 5.962.170 35.71%
2016 218.933.000 97.28%
2017 1.563.131.000 85.99%
2018 4.390.047.000 64.39%
2019 2.126.450.000 -106.45%
2020 2.037.700.000 -4.36%
2021 662.354.000 -207.65%
2022 517.137.000 -28.08%
2022 662.354.000 21.92%
2023 601.870.000 -10.05%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Aurora Cannabis Inc. Assets
Year Assets Growth
2006 445.062
2007 1.691.834 73.69%
2008 1.627.417 -3.96%
2009 1.729.534 5.9%
2010 1.388.069 -24.6%
2011 1.121.220 -23.8%
2012 718.545 -56.04%
2013 1.887.349 61.93%
2014 13.526.622 86.05%
2015 18.396.545 26.47%
2016 322.679.000 94.3%
2017 1.910.716.000 83.11%
2018 5.502.830.000 65.28%
2019 2.783.695.000 -97.68%
2020 2.604.731.000 -6.87%
2021 1.084.356.000 -140.21%
2022 926.322.000 -17.06%
2022 1.084.356.000 14.57%
2023 838.673.000 -29.29%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Aurora Cannabis Inc. Liabilities
Year Liabilities Growth
2006 14.840
2007 6.575 -125.7%
2008 8.330 21.07%
2009 15.322 45.63%
2010 15.443 0.78%
2011 46.668 66.91%
2012 24.345 -91.69%
2013 533.988 95.44%
2014 9.693.812 94.49%
2015 12.434.375 22.04%
2016 103.746.000 88.01%
2017 347.585.000 70.15%
2018 1.112.783.000 68.76%
2019 657.245.000 -69.31%
2020 567.031.000 -15.91%
2021 422.002.000 -34.37%
2022 409.185.000 -3.13%
2022 422.002.000 3.04%
2023 236.803.000 -78.21%

Aurora Cannabis Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
5.18
Net Income per Share
-13.98
Price to Earning Ratio
-0.53x
Price To Sales Ratio
1.64x
POCF Ratio
-4.17
PFCF Ratio
-3.81
Price to Book Ratio
0.62
EV to Sales
1.61
EV Over EBITDA
-9.64
EV to Operating CashFlow
-4.7
EV to FreeCashFlow
-3.73
Earnings Yield
-1.9
FreeCashFlow Yield
-0.26
Market Cap
0,40 Bil.
Enterprise Value
0,39 Bil.
Graham Number
60.93
Graham NetNet
0.17

Income Statement Metrics

Net Income per Share
-13.98
Income Quality
0.13
ROE
-1.18
Return On Assets
-0.79
Return On Capital Employed
-0.13
Net Income per EBT
1.01
EBT Per Ebit
6.85
Ebit per Revenue
-0.39
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0.47
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0.05
Gross Profit Margin
0.45
Operating Profit Margin
-0.39
Pretax Profit Margin
-2.69
Net Profit Margin
-2.7

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-1.77
Free CashFlow per Share
-2.23
Capex to Operating CashFlow
-0.26
Capex to Revenue
0.09
Capex to Depreciation
0.49
Return on Invested Capital
-0.14
Return on Tangible Assets
-0.88
Days Sales Outstanding
67.53
Days Payables Outstanding
54.69
Days of Inventory on Hand
501.48
Receivables Turnover
5.41
Payables Turnover
6.67
Inventory Turnover
0.73
Capex per Share
0.46

Balance Sheet

Cash per Share
2,48
Book Value per Share
12,69
Tangible Book Value per Share
10.92
Shareholders Equity per Share
11.8
Interest Debt per Share
2.71
Debt to Equity
0.19
Debt to Assets
0.12
Net Debt to EBITDA
0.21
Current Ratio
3.42
Tangible Asset Value
0,52 Bil.
Net Current Asset Value
0,19 Bil.
Invested Capital
680339000
Working Capital
0,30 Bil.
Intangibles to Total Assets
0.1
Average Receivables
0,04 Bil.
Average Payables
0,02 Bil.
Average Inventory
165166000
Debt to Market Cap
0.26

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Aurora Cannabis Inc. Dividends
Year Dividends Growth

Aurora Cannabis Inc. Profile

About Aurora Cannabis Inc.

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

CEO
Mr. Miguel Martin
Employee
1.073
Address
500 - 10355 Jasper Avenue
Edmonton, T5J 1Y6

Aurora Cannabis Inc. Executives & BODs

Aurora Cannabis Inc. Executives & BODs
# Name Age
1 Ms. Nathalie Clark
Executive Vice President, General Counsel & Corporate Secretary
70
2 Ms. Lori Schick
Executive Vice President of Human Resources
70
3 Mr. Miguel Martin
Chief Executive Officer & Executive Chairman
70
4 Ananth Krishnan
Vice President of Capital Markets & Investor Relations
70
5 Mr. Alex Miller
Executive Vice President of Operations & Supply Chain
70
6 Mr. Andre Jerome
Executive Vice President of Global Business Development
70
7 Michelle Lefler
Vice President of Communications & Public Relations
70
8 Mr. Rick Savone
Senior Vice President of Global Government Relations
70
9 Ms. Simona King
Chief Financial Officer
70
10 Dr. Jonathan Page Ph.D.
Senior Science Advisor
70

Aurora Cannabis Inc. Competitors